VICTORION-Mono China: efficacy and safety of inclisiran as monotherapy in Chinese adults with low or moderate ASCVD risk and elevated LDL-C
29 August 2025 (10:00 - 10:45)
Organised by: 
Abstract
About the speaker
(Switzerland)
9 More presentations in this session
Access the full session
The Event
ESC Congress 2025
29 August 2025
10:00 CET
